Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.54 |
| ▸ | KIF11 | P52732 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29939003 | 1.00 | RAPGEF4 (0.54) | RAPGEF4KIF11TP53HTTL3MBTL1 | |
| SCHEMBL5144284 | 0.87 | RAPGEF4 (0.53) | RAPGEF4MAPTSIGMAR1MEN1KMT2A | |
| SCHEMBL8896899 | 0.87 | RAPGEF4 (0.67) | RAPGEF4KIF11TP53HTTL3MBTL1 | |
| SCHEMBL4701514 | 0.85 | RAPGEF4 (0.61) | RAPGEF4KIF11TP53HTTL3MBTL1 | |
| SCHEMBL8067239 | 0.82 | RAPGEF4 (0.54) | RAPGEF4KIF11TP53HTTL3MBTL1 | |
| SCHEMBL8075313 | 0.82 | RAPGEF4 (0.54) | RAPGEF4KIF11TP53HTTL3MBTL1 | |
| SCHEMBL5543379 | 0.79 | RAPGEF4 (0.54) | RAPGEF4KIF11TP53HTTL3MBTL1 | |
| SCHEMBL1851950 | 0.78 | ALDH1A1 (0.62) | HTTL3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL8897281 | 0.78 | RAPGEF4 (0.67) | RAPGEF4KIF11TP53HTTL3MBTL1 | |
| SCHEMBL28542938 | 0.76 | RAPGEF4 (0.56) | RAPGEF4KIF11TP53HTTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220283032-A1 | Hair Colorant Assessment, Selection And Formulation System | Innovative Beauty LLC (US) | 2022-09-08 | — | — | US | disclosed |
| US-11378457-B1 | Hair colorant assessment, selection and formulation system | Innovative Beauty LLC (US) | 2022-07-05 | — | — | US | disclosed |
| US-11137291-B1 | Hair colorant assessment, selection and formulation system | Innovative Beauty LLC (US) | 2021-10-05 | — | — | US | disclosed |
| US-6986886-B2 | Hair conditioning compositions and their use in hair coloring compositions | THE PROCTER & GAMBLE COMPANY (US) | 2006-01-17 | — | — | US | disclosed |
| US-20040158941-A1 | Hair colouring and conditioning compositions | THE PROCTER & GAMBLE COMPANY (US) | 2004-08-19 | — | — | US | disclosed |
| US-20040158938-A1 | Method for colouring hair | THE PROCTER & GAMBLE COMPANY | 2004-08-19 | — | — | US | disclosed |
| US-6758866-B2 | AQUEOUS SOLUTION OF CHELATE COMPOUND, OXIDATION COLOR DYE AND COUPLER | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-07-06 | — | — | US | disclosed |
| US-6695888-B2 | COMPLEX TRANSITION METAL HAIR DYE | UNILEVER HOME & PERSONAL CARE, USA, DIVISION OF CONOPCO, INC. | 2004-02-24 | — | — | US | disclosed |
| WO-2004014328-A1 | ONE STEP HAIR COLORING COMPOSITIONS COMPRISING WATER SOLUBLE CARBONATE RELEASING SALTS | UNILEVER PLC (GB) | 2004-02-19 | — | — | WO | disclosed |
| US-20040019980-A1 | One step hair coloring compositions using salts | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-02-05 | — | — | US | disclosed |
| EP-0869769-A1 | HAIR BLEACHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-10-14 | — | — | EP | disclosed |
| WO-1998027943-A1 | HAIR COLORING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027945-A1 | HAIR COLORING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027944-A1 | HAIR COLORING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1998027942-A1 | HAIR COLORING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-07-02 | — | — | WO | disclosed |
| WO-1997024106-A1 | HAIR COLORING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997024105-A1 | HAIR COLORING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997024107-A1 | HAIR COLORING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-07-10 | — | — | WO | disclosed |
| WO-1997024108-A1 | HAIR BLEACHING COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-07-10 | — | — | WO | disclosed |
| US-3957424-A | Enzyme-activated oxidative process for coloring hair | THE PROCTER & GAMBLE COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040158941-A1 | Hair colouring and conditioning compositions | FNIP1, CUTA, SHH | RAPGEF4 4523/4885KIF11 3879/4885TP53 351/4885 |
| US-20040158938-A1 | Method for colouring hair | COX5B, SHH, DNMT3A | RAPGEF4 4272/4885KIF11 4013/4885TP53 1773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.